Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) EBIT Margin (2016 - 2025)

AtriCure (ATRC) has disclosed EBIT Margin for 16 consecutive years, with 1.77% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 1346.0% to 1.77% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.77% through Dec 2025, up 683.0% year-over-year, with the annual reading at 1.77% for FY2025, 683.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 1.77% at AtriCure, up from 0.15% in the prior quarter.
  • The five-year high for EBIT Margin was 140.04% in Q3 2021, with the low at 26.8% in Q1 2021.
  • Average EBIT Margin over 5 years is 2.3%, with a median of 7.26% recorded in 2023.
  • The sharpest move saw EBIT Margin surged 14732bps in 2021, then crashed -15292bps in 2022.
  • Over 5 years, EBIT Margin stood at 17.08% in 2021, then skyrocketed by 72bps to 4.7% in 2022, then tumbled by -73bps to 8.14% in 2023, then crashed by -44bps to 11.69% in 2024, then soared by 115bps to 1.77% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 1.77%, 0.15%, and 4.55% for Q4 2025, Q3 2025, and Q2 2025 respectively.